June 13, 2017 / 11:15 AM / 6 months ago

BRIEF-Axovant Sciences' Q4 loss per share $0.53

June 13 (Reuters) - Axovant Sciences Ltd

* Axovant Sciences announces fiscal year-end financial results and corporate updates

* Q4 loss per share $0.53

* Q4 earnings per share view $-0.51 -- Thomson Reuters I/B/E/S

* Expects to meet with U.S. Food and Drug Administration to discuss additional studies that could support registration of RVT-103

* Axovant Sciences Ltd says expects to initiate a proof of concept study for RVT-104 in second half of 2017 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below